Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

Clinical trial NCT05476939 · RECRUITING

Trial details

NCT number: NCT05476939
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma, H3 K27M-Mutant Diffuse Midline Glioma, H3K27-altered

Start date: 2022-09-29
Primary completion: 2028-09-01
Enrollment: 433

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.